Source: Health Products Regulatory Authority (ZA) Revision Year: 2022 Publisher: Acino Pharma (Pty) Ltd, 106 16th Road, Midrand, 1686
GRANTRYL is indicated for the prevention of:
Prevention:
The dose of GRANTRYL is 1 mg twice a day or 2 mg once a day, for up to one week following chemotherapy. The first dose of GRANTRYL should be administered within one hour before the start of therapy.
The dose of GRANTRYL is 2 mg once a day, for up to one week following radiotherapy. The first dose of GRANTRYL should be administered within one hour before the start of therapy.
No dosage adjustments required.
No dosage adjustments required.
No dosage adjustments required.
Although present experience indicates that no dosage adjustment is required, care should be exercised when administering GRANTRYL to elderly patients and patients with renal or hepatic impairment.
GRANTRYL is contraindicated in children under the age of 2 years (see section 4.3). There is insufficient information to recommend use of GRANTRYL in the prevention of RINV in children.
For oral administration
Headaches may occur. Granisetron, as GRANTRYL, may prolong the QT interval.
There is no specific antidote for GRANTRYL. In the case of overdosage, symptomatic and supportive treatment should be given. ECG monitoring is recommended in case of overdose with GRANTRYL.
36 months.
Store at or below 25°C protected from light and moisture.
Keep in original packaging until required for use.
1, 5, 10 and 100 film-coated tablets are packed in a white opaque polyvinyl chloride film blister strip sealed with an aluminium foil backing. The blister strips are packed into an outer cardboard carton together with a leaflet.
Not all pack sizes are necessarily marketed.
No special requirements.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
